| 1 |
Li Y, Teng D, Ba J, et al. Efficacy and safety of long-term universal salt iodization on thyroid disorders: Epidemiological evidence from 31 provinces of mainland China [J]. Thyroid, 2020,30(4): 568-579.
|
| 2 |
孙世怡, 胡玉萍, 田济铭, 等. 雌孕激素及其受体与甲状腺疾病关系的研究进展 [J]. 大连医科大学学报, 2018,40(4): 364-367.
|
| 3 |
王美荣, 赵淑玲, 陈云霞. 女性甲状腺功能紊乱与性激素的相关性分析 [J]. 中文科技期刊数据库(全文版)医药卫生, 2022(10): 7-9.
|
| 4 |
López-Fontana CM, Sasso CV, Maselli ME, et al. Experimental hypothyroidism increases apoptosis in dimethylbenzanthracene-induced mammary tumors [J]. Oncol Rep, 2013,30(4): 1651-1660.
|
| 5 |
徐晓棠, 张巧红, 蒋锦文. 亚临床甲减对女性的性激素水平影响与分析 [J]. 医学理论与实践, 2016,29(9): 1226-1227.
|
| 6 |
Hernandez A. Thyroid hormone deiodination and action in the gonads [J]. Curr Opin Endocr Metab Res, 2018,2: 18-23.
|
| 7 |
Vissenberg R, Manders VD, Mastenbroek S, et al. Pathophysiological aspects of thyroid hormone disorders/thyroid peroxidase autoantibodies and reproduction [J]. Hum Reprod Update, 2015,21(3): 378-387.
|
| 8 |
Hernandez A. Thyroid hormone role and economy in the developing testis [J]. Vitam Horm, 2018,106: 473-500.
|
| 9 |
Pekcan MK, Ozgu-Erdinc AS, Yilmaz N. Impact of subclinical hypothyroidism and thyroid autoimmunity on clinical pregnancy rate after intrauterine insemination in euthyroid women [J]. JBRA Assist Reprod, 2019,23(2): 137-142.
|
| 10 |
郑铁生, 叶立新, 吴志勇. 男性甲亢患者治疗前后血清性激素水平观察 [J]. 中华男科学杂志, 2005,11(12): 936-938.
|
| 11 |
马婉璐, 王曦, 茅江峰, 等. 青中年男性甲状腺功能亢进症患者治疗前后性激素和性激素结合球蛋白的变化 [J]. 中华医学杂志, 2019,99(24): 1875-1880.
|
| 12 |
许伟伟, 刘玥隽, 赵琳, 等. Graves病患者性激素与性激素结合球蛋白水平的相关性研究 [J]. 中华内分泌代谢杂志, 2020,36(6): 479-484.
|
| 13 |
陈逗逗, 刘坤钰, 郑旭琴. 甲状腺疾病对生殖障碍的影响 [J]. 中国现代医学杂志, 2020,30(16): 55-58.
|
| 14 |
Hekimsoy Z, Kafesçiler S, Güçlü F, et al. The prevalence of hyperprolactinaemia in overt and subclinical hypothyroidism [J]. Endocr J, 2010,57(12): 1011-1015.
|
| 15 |
魏子坤. 甲状腺功能异常与高泌乳素血症 [J]. 放射免疫学杂志, 2011,24(1): 47-50.
|
| 16 |
李丹, 李琳, 郭连坤. 血清性激素水平检测诊断甲状腺功能减退的价值 [J]. 中国卫生标准管理, 2020,11(14): 122-124.
|
| 17 |
Akirov A, Gimbel H, Grossman A, et al. Elevated TSH in adults treated for hypothyroidism is associated with increased mortality [J]. Eur J Endocrinol, 2017,176(1): 57-66.
|
| 18 |
Kamel SR, Mohammud HM. Evaluation of the serum thyroid hormones and its effect/complications during pregnancy [J]. J Public Health Res, 2019,10(11): 2176-2179.
|
| 19 |
Dittrich R, Kajaia N, Cupisti S, et al. Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS [J]. Reprod Biomed Online, 2009,19(3):319-325.
|
| 20 |
陈凌志, 刘启龙, 谌红珊, 等. 妊娠期亚临床甲状腺功能减退的合理诊断 [J/OL]. 中华临床医师杂志(电子版), 2017,11(17): 2184-2188.
URL
|
| 21 |
Aghajanova L, Lindeberg M, Carlsson IB, et al. Receptors for thyroid-stimulating hormone and thyroid hormones in human ovarian tissue [J]. Reprod Biomed Online, 2009,18(3): 337-347.
|
| 22 |
张旭帆, 唐思洋, 蒋琴, 等. 甲状腺功能减退伴高泌乳素血症女性患者的PRL水平与甲减症状的相关性研究 [J/OL]. 临床检验杂志(电子版), 2020,9(3): 309-310.
|
| 23 |
邱蕾, 孙明晓, 汪耀, 等. 中年至超高龄老年人甲状腺结节的发病特点 [J]. 中华内分泌代谢杂志, 2014,30(2): 115-118.
|
| 24 |
Singh Ospina N, Maraka S, Espinosa De Ycaza AE, et al. Physical exam in asymptomatic people drivers the detection of thyroid nodules undergoing ultrasound guided fine needle aspiration biopsy [J]. Endocrine, 2016,54(2): 433-439.
|
| 25 |
叶月, 甄洁玉, 闵行, 等. 绝经女性生殖因素与甲状腺结节的相关性研究 [J]. 陆军军医大学学报, 2023,45(6): 554-560.
|
| 26 |
宋立稳,王小龙,程丽霞.甲状腺结节的规范化诊疗 [J/OL]. 中华临床医师杂志(电子版), 2017,11(17): 2189-2192.
URL
|
| 27 |
Derwahl M, Nicula D. Estrogen and its role in thyroid cancer [J]. Endocr Relat Cancer, 2014,21(5): T273-T283.
|
| 28 |
李周靖, 黄志毅, 熊卿. 成人甲状腺结节与性激素水平的相关性分析 [J]. 中国当代医药, 2019,26(23): 24-26,30.
|
| 29 |
孙娜娜, 韩立坤. 男性2型糖尿病合并良性甲状腺结节患者的内分泌激素特征 [J]. 中国医科大学学报, 2019,48(6): 515-518,524.
|
| 30 |
王昱骄. 围绝经期桥本甲状腺炎合并甲状腺癌患者女性激素水平及受体表达 [D]. 长春中医药大学外科学, 2020.
|
| 31 |
常伟勤, 李凤, 吴书莹, 等. 围绝经期女性雌激素水平与桥本氏甲状腺炎的相关性研究[J]. 中国实验诊断学, 2016,20(9): 1501-1503.
|
| 32 |
汪正园, 臧嘉捷, 吴凡. 甲状腺癌及其危险因素 [J]. 环境与职业医学, 2021,38(11): 1169-1172.
|
| 33 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017 [J]. CA Cancer J Clin, 2017,67(1): 7-30.
|
| 34 |
Rajoria S, Suriano R, George AL, et al. Estrogen activity as a preventive and therapeutic target in thyroid cancer [J]. Biomedicine & Pharmacotherapy, 2012,66(2): 151-158.
|
| 35 |
董愫, 宋雪松, 庞磊, 等. 女性甲状腺结节患者性激素水平及其受体表达的研究 [J]. 中华内分泌外科杂志, 2017,11(1): 29-33.
|
| 36 |
贺小威, 赵越. 雌激素受体在甲状腺癌中的作用 [J]. 中国细胞生物学学报, 2017,39(9): 1220-1227.
|
| 37 |
Ahmed RA, Aboelnaga EM. Thyroid cancer in egypt: Histopathological criteria, correlation with survival and oestrogen receptor protein expression [J]. Pathology & Oncology Research, 2015,21(3): 793-802.
|
| 38 |
Yi JW, Kim SJ, Kim JK, et al. Upregulation of the ESR1 gene and ESR ratio (ESR1/ESR2) is associated with a worse prognosis in papillary thyroid carcinoma: The impact of the estrogen receptor α/β expression on clinical outcomes in papillary thyroid carcinoma patients [J]. Ann Surg Oncol, 2017,24(12): 3754-3762.
|
| 39 |
吴丹, 漆仲文, 方文岩, 等. 乳腺癌与甲状腺疾病的相关性研究概述 [J]. 现代肿瘤医学, 2021,29(5): 896-900.
|